EMEA-002486-PIP04-21-M01
Submitted by Anonymous (not verified) on 11 June 2025 - 15:04
EMEA-002486-PIP04-21-M01
EMEA-000813-PIP01-09-M01
Submitted by Anonymous (not verified) on 11 June 2025 - 14:39
EMEA-000813-PIP01-09-M01
Opinion/decision on a Paediatric investigation plan (PIP): Eliquis, Apixaban, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Cardiovascular diseases, PIP number: P/0135/2024
Submitted by Anonymous (not verified) on 11 June 2025 - 14:35
Opinion/decision on a Paediatric investigation plan (PIP): Eliquis, Apixaban, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Cardiovascular diseases, PIP number: P/0135/2024
EMEA-003623-PIP01-24
Submitted by Anonymous (not verified) on 11 June 2025 - 14:24
EMEA-003623-PIP01-24
EMEA-003624-PIP01-24
Submitted by Anonymous (not verified) on 11 June 2025 - 14:24
EMEA-003624-PIP01-24
EMEA-003573-PIP01-23
Submitted by Anonymous (not verified) on 11 June 2025 - 14:18
EMEA-003573-PIP01-23
EMEA-003570-PIP01-23
Submitted by Anonymous (not verified) on 11 June 2025 - 14:13
EMEA-003570-PIP01-23
EMEA-003567-PIP01-23
Submitted by Anonymous (not verified) on 11 June 2025 - 14:10
EMEA-003567-PIP01-23
Opinion/decision on a Paediatric investigation plan (PIP): Vyvgart, Efgartigimod alfa, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Eye disorders, PIP number: P/0111/2024
Submitted by Anonymous (not verified) on 11 June 2025 - 13:52
Opinion/decision on a Paediatric investigation plan (PIP): Vyvgart, Efgartigimod alfa, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Eye disorders, PIP number: P/0111/2024
EMEA-003566-PIP01-23
Submitted by Anonymous (not verified) on 11 June 2025 - 13:34
EMEA-003566-PIP01-23